Making medicines safer: analysis of patient reports to the UK’s Yellow Card Scheme-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Making medicines safer: analysis of patient reports to the UK’s Yellow Card Scheme

Published:2019-09-20 Issue:12 Volume:18 Page:1237-1243
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

O’ Donovan B.¹^ORCID,Rodgers Ruth M.²,Cox Anthony R.³,Krska Janet²

Affiliation:

1. School of Medicine, Trinity College Dublin, Dublin, Ireland

2. Medway School of Pharmacy, Universities of Kent and Greenwich at Medway, Kent, UK

3. School of Pharmacy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2019.1669559

Reference27 articles.

1. Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes

2. Adverse Drug Reaction Reporting by Patients in the Netherlands

3. Evaluation of patient reporting of adverse drug reactions to the UK ‘Yellow Card Scheme’: literature review, descriptive and qualitative analyses, and questionnaire surveys

4. How Do Patients Contribute to Signal Detection?

5. The value of patient reporting to the pharmacovigilance system: a systematic review

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. All-round approaches to increase adverse drug reaction reports: a scoping review;Drugs & Therapy Perspectives;2023-06-16

2. Sex, Gender, and the Regulation of Prescription Drugs: Omissions and Opportunities;International Journal of Environmental Research and Public Health;2023-02-08

3. Classifying Drug Ratings Using User Reviews with Transformer-Based Language Models;2022 IEEE 10th International Conference on Healthcare Informatics (ICHI);2022-06

4. Identifying and managing adverse drug reactions: Qualitative analysis of patient reports to the UK yellow card scheme;British Journal of Clinical Pharmacology;2022-03-23

5. A Sex- and Gender-Based Analysis of Adverse Drug Reactions: A Scoping Review of Pharmacovigilance Databases;Pharmaceuticals;2022-02-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3